Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels
- PMID: 12930735
- DOI: 10.1182/blood-2003-05-1629
Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels
Comment on
-
Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib.Blood. 2003 Jun 1;101(11):4611-4. doi: 10.1182/blood-2002-12-3659. Epub 2003 Feb 6. Blood. 2003. PMID: 12576318
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous

